"Designing Growth Strategies is in our DNA"

In-vitro Diagnostics (IVD) Market Size, Share & Industry Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Immunodiagnostics [Enzyme Linked Immunosorbent Assay, Fluorescence immunoassay, Rapid test], Clinical Chemistry, Molecular Diagnostics, Hematology), By Sample (Blood, Urine, Saliva, Tissue), By Setting (Laboratories, Point-of-Care), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Allergy), By End-user (Clinical Laboratories, Hospitals, Physician’s Offices), & Regional Forecast, 2026-2034

Last Updated: December 29, 2025 | Format: PDF | Report ID: FBI101443

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Diseases, by Countries/Region in 2025
    2. New Product Launches by Key Players
    3. Recent Industry Developments - Mergers & Acquisitions
    4. Overview of Healthcare Expenditure by Key Countries
    5. Technological Advancements, IVD Instruments & Kits
    6. Impact of COVID-19 on the In-Vitro Diagnostics Market
  5. Global In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Setting
      2. Canada
        1. By Setting
  7. Europe In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Germany
        1. By Setting
      2. U.K.
        1. By Setting
      3. France
        1. By Setting
      4. Italy
        1. By Setting
      5. Spain
        1. By Setting
      6. Scandinavia
        1. By Setting
      7. Rest of Europe
        1. By Setting
  8. Asia Pacific In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Setting
      2. Japan
        1. By Setting
      3. India
        1. By Setting
      4. Australia
        1. By Setting
      5. Southeast Asia
        1. By Setting
      6. Rest of Asia Pacific
        1. By Setting
  9. Latin America In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Setting
      2. Mexico
        1. By Setting
      3. Rest of Latin America
        1. By Setting
  10. Middle East & Africa In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Setting
      2. South Africa
        1. By Setting
      3. Rest of Middle East & Africa
        1. By Setting
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Profiles of Players Operating in the Market
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      2. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      3. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      4. Sysmex Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      5. Siemens Healthineers AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      6. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      7. Seegene Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      8. DiaSorin S.p.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      9. Quest Diagnostics Incorporated
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      10. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Diseases, by Countries/Region in 2025
    2. New Product Launches by Key Players
    3. Recent Industry Developments - Mergers & Acquisitions
    4. Overview of Healthcare Expenditure by Key Countries
    5. Technological Advancements, IVD Instruments & Kits
    6. Impact of COVID-19 on the In-Vitro Diagnostics Market
  5. Global In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Setting
      2. Canada
        1. By Setting
  7. Europe In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Germany
        1. By Setting
      2. U.K.
        1. By Setting
      3. France
        1. By Setting
      4. Italy
        1. By Setting
      5. Spain
        1. By Setting
      6. Scandinavia
        1. By Setting
      7. Rest of Europe
        1. By Setting
  8. Asia Pacific In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Setting
      2. Japan
        1. By Setting
      3. India
        1. By Setting
      4. Australia
        1. By Setting
      5. Southeast Asia
        1. By Setting
      6. Rest of Asia Pacific
        1. By Setting
  9. Latin America In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Setting
      2. Mexico
        1. By Setting
      3. Rest of Latin America
        1. By Setting
  10. Middle East & Africa In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-linked immunosorbent Assays (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    5. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    6. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physician’s Offices
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Setting
      2. South Africa
        1. By Setting
      3. Rest of Middle East & Africa
        1. By Setting
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Profiles of Players Operating in the Market
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      2. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      3. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      4. Sysmex Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      5. Siemens Healthineers AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      6. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      7. Seegene Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      8. DiaSorin S.p.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      9. Quest Diagnostics Incorporated
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      10. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global In-vitro Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global In-vitro Diagnostics Market Value Share (%), by Product Type, 2025 & 2034

Figure 3: Global In-vitro Diagnostics Market Value Share (%), by Technique, 2025 & 2034

Figure 4: Global In-vitro Diagnostics Market Value Share (%), by Sample Type, 2025 & 2034

Figure 5: Global In-vitro Diagnostics Market Value Share (%), by Setting, 2025 & 2034

Figure 6: Global In-vitro Diagnostics Market Value Share (%), by Application, 2025 & 2034

Figure 7: Global In-vitro Diagnostics Market Value Share (%), by End User, 2025 & 2034

Figure 8: Global In-vitro Diagnostics Market Value Share (%), by Region, 2025 & 2034

Figure 9: North America In-vitro Diagnostics Market Value (USD billion), by Product Type, 2025 & 2034

Figure 10: North America In-vitro Diagnostics Market Value Share (%), by Product Type, 2025

Figure 11: North America In-vitro Diagnostics Market Value (USD billion), by Technique, 2025 & 2034

Figure 12: North America In-vitro Diagnostics Market Value Share (%), by Technique, 2025

Figure 13: North America In-vitro Diagnostics Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 14: North America In-vitro Diagnostics Market Value Share (%), by Sample Type, 2025

Figure 15: North America In-vitro Diagnostics Market Value (USD billion), by Setting, 2025 & 2034

Figure 16: North America In-vitro Diagnostics Market Value Share (%), by Setting, 2025

Figure 17: North America In-vitro Diagnostics Market Value (USD billion), by Application, 2025 & 2034

Figure 18: North America In-vitro Diagnostics Market Value Share (%), by Application, 2025

Figure 19: North America In-vitro Diagnostics Market Value (USD billion), by End User, 2025 & 2034

Figure 20: North America In-vitro Diagnostics Market Value Share (%), by End User, 2025

Figure 21: North America In-vitro Diagnostics Market Value (USD billion), By Country, 2025 & 2034

Figure 22: North America In-vitro Diagnostics Market Value Share (%), By Country, 2025

Figure 23: Europe In-vitro Diagnostics Market Value (USD billion), by Product Type, 2025 & 2034

Figure 24: Europe In-vitro Diagnostics Market Value Share (%), by Product Type, 2025

Figure 25: Europe In-vitro Diagnostics Market Value (USD billion), by Technique, 2025 & 2034

Figure 26: Europe In-vitro Diagnostics Market Value Share (%), by Technique, 2025

Figure 27: Europe In-vitro Diagnostics Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 28: Europe In-vitro Diagnostics Market Value Share (%), by Sample Type, 2025

Figure 29: Europe In-vitro Diagnostics Market Value (USD billion), by Setting, 2025 & 2034

Figure 30: Europe In-vitro Diagnostics Market Value Share (%), by Setting, 2025

Figure 31: Europe In-vitro Diagnostics Market Value (USD billion), by Application, 2025 & 2034

Figure 32: Europe In-vitro Diagnostics Market Value Share (%), by Application, 2025

Figure 33: Europe In-vitro Diagnostics Market Value (USD billion), by End User, 2025 & 2034

Figure 34: Europe In-vitro Diagnostics Market Value Share (%), by End User, 2025

Figure 35: Europe In-vitro Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36: Europe In-vitro Diagnostics Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Asia Pacific In-vitro Diagnostics Market Value (USD billion), by Product Type, 2025 & 2034

Figure 38: Asia Pacific In-vitro Diagnostics Market Value Share (%), by Product Type, 2025

Figure 39: Asia Pacific In-vitro Diagnostics Market Value (USD billion), by Technique, 2025 & 2034

Figure 40: Asia Pacific In-vitro Diagnostics Market Value Share (%), by Technique, 2025

Figure 41: Asia Pacific In-vitro Diagnostics Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 42: Asia Pacific In-vitro Diagnostics Market Value Share (%), by Sample Type, 2025

Figure 43: Asia Pacific In-vitro Diagnostics Market Value (USD billion), by Setting, 2025 & 2034

Figure 44: Asia Pacific In-vitro Diagnostics Market Value Share (%), by Setting, 2025

Figure 45: Asia Pacific In-vitro Diagnostics Market Value (USD billion), by Application, 2025 & 2034

Figure 46: Asia Pacific In-vitro Diagnostics Market Value Share (%), by Application, 2025

Figure 47: Asia Pacific In-vitro Diagnostics Market Value (USD billion), by End User, 2025 & 2034

Figure 48: Asia Pacific In-vitro Diagnostics Market Value Share (%), by End User, 2025

Figure 49: Asia Pacific In-vitro Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 50: Asia Pacific In-vitro Diagnostics Market Value Share (%), By Country/ Sub-region, 2025

Figure 51: Latin America In-vitro Diagnostics Market Value (USD billion), by Product Type, 2025 & 2034

Figure 52: Latin America In-vitro Diagnostics Market Value Share (%), by Product Type, 2025

Figure 53: Latin America In-vitro Diagnostics Market Value (USD billion), by Technique, 2025 & 2034

Figure 54: Latin America In-vitro Diagnostics Market Value Share (%), by Technique, 2025

Figure 55: Latin America In-vitro Diagnostics Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 56: Latin America In-vitro Diagnostics Market Value Share (%), by Sample Type, 2025

Figure 57: Latin America In-vitro Diagnostics Market Value (USD billion), by Setting, 2025 & 2034

Figure 58: Latin America In-vitro Diagnostics Market Value Share (%), by Setting, 2025

Figure 59: Latin America In-vitro Diagnostics Market Value (USD billion), by Application, 2025 & 2034

Figure 60: Latin America In-vitro Diagnostics Market Value Share (%), by Application, 2025

Figure 61: Latin America In-vitro Diagnostics Market Value (USD billion), by End User, 2025 & 2034

Figure 62: Latin America In-vitro Diagnostics Market Value Share (%), by End User, 2025

Figure 63: Latin America In-vitro Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 64: Latin America In-vitro Diagnostics Market Value Share (%), By Country/ Sub-region, 2025

Figure 65: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), by Product Type, 2025 & 2034

Figure 66: Middle East & Africa In-vitro Diagnostics Market Value Share (%), by Product Type, 2025

Figure 67: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), by Technique, 2025 & 2034

Figure 68: Middle East & Africa In-vitro Diagnostics Market Value Share (%), by Technique, 2025

Figure 69: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 70: Middle East & Africa In-vitro Diagnostics Market Value Share (%), by Sample Type, 2025

Figure 71: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), by Setting, 2025 & 2034

Figure 72: Middle East & Africa In-vitro Diagnostics Market Value Share (%), by Setting, 2025

Figure 73: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), by Application, 2025 & 2034

Figure 74: Middle East & Africa In-vitro Diagnostics Market Value Share (%), by Application, 2025

Figure 75: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), by End User, 2025 & 2034

Figure 76: Middle East & Africa In-vitro Diagnostics Market Value Share (%), by End User, 2025

Figure 77: Middle East & Africa In-vitro Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 78: Middle East & Africa In-vitro Diagnostics Market Value Share (%), By Country/ Sub-region, 2025

Figure 79: Global In-vitro Diagnostics Market Share (%), By Company, 2025

Table 1: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 2: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 3: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 4: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 5: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 6: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 7: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 8: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 9: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 10: Global In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 11: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 12: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 13: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 14: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 15: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 16: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 17: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 18: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 19: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 20: North America In-vitro Diagnostics Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 21: U.S. In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 22: Canada In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 23: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 24: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 25: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 26: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 27: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 28: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 29: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 30: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 31: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 32: Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 33: Germany In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 34: U.K. In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 35: France In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 36: Italy In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 37: Spain In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 38: Scandinavia In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 39: Rest of Europe In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 40: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 41: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 42: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 43: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 44: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 45: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 46: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 47: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 48: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 49: Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 50: China In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 51: Japan In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 52: India In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 53: Australia In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 54: Southeast Asia In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 55: Rest of Asia Pacific In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 56: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 57: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 58: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 59: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 60: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 61: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 62: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 63: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 64: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 65: Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 66: Brazil In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 67: Mexico In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 68: Rest of Latin America In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 69: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 70: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 71: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 72: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 73: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 74: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 75: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 76: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 77: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 78: Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 79: GCC In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 80: South Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 81: Rest of Middle East & Africa In-vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2021–2034

In-vitro Diagnostics (IVD) Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 290
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports